ATE447586T1 - Fprl1-liganden und deren verwendung - Google Patents

Fprl1-liganden und deren verwendung

Info

Publication number
ATE447586T1
ATE447586T1 AT03810620T AT03810620T ATE447586T1 AT E447586 T1 ATE447586 T1 AT E447586T1 AT 03810620 T AT03810620 T AT 03810620T AT 03810620 T AT03810620 T AT 03810620T AT E447586 T1 ATE447586 T1 AT E447586T1
Authority
AT
Austria
Prior art keywords
fprl1
seq
amino acid
acid sequence
ligands
Prior art date
Application number
AT03810620T
Other languages
English (en)
Inventor
Shuji Hinuma
Makoto Kobayashi
Yugo Habata
Masataka Harada
Shoichi Okubo
Hiromi Yoshida
Kazunori Nishi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE447586T1 publication Critical patent/ATE447586T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03810620T 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung ATE447586T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002324189 2002-11-07
JP2002367119 2002-12-18
JP2003059073 2003-03-05
JP2003191359 2003-07-03
PCT/JP2003/014138 WO2004041850A1 (ja) 2002-11-07 2003-11-06 新規なfprl1リガンドおよびその用途

Publications (1)

Publication Number Publication Date
ATE447586T1 true ATE447586T1 (de) 2009-11-15

Family

ID=32314929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03810620T ATE447586T1 (de) 2002-11-07 2003-11-06 Fprl1-liganden und deren verwendung

Country Status (6)

Country Link
US (1) US7943137B2 (de)
EP (1) EP1559721B1 (de)
AT (1) ATE447586T1 (de)
AU (1) AU2003277575A1 (de)
DE (1) DE60329931D1 (de)
WO (1) WO2004041850A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002332929A1 (en) 2001-09-07 2003-03-24 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39
AU2007357448B2 (en) 2006-09-18 2012-09-06 Compugen Ltd Bioactive peptides and method of using same
JP5982001B2 (ja) 2011-10-26 2016-08-31 アラーガン、インコーポレイテッドAllergan,Incorporated ホルミルペプチド受容体様1(fprl−1)受容体モジュレーターとしてのn−尿素置換アミノ酸のアミド誘導体
CA2898301C (en) * 2013-03-06 2021-11-16 Allergan, Inc. Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2030000A (en) 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
AU2754600A (en) * 2000-02-04 2001-08-14 Us Health Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
CA2402238C (en) * 2000-03-07 2011-12-13 Japan Tobacco Inc. Polypeptides having neutrophil stimulating activity
US7172876B2 (en) 2002-06-14 2007-02-06 Takeda Pharmaceutical Company Limited Method of screening therapeutic agents for nerve degeneration associated diseases
AU2003242342A1 (en) 2002-07-15 2004-02-02 Takeda Chemical Industries, Ltd. Novel screening method

Also Published As

Publication number Publication date
DE60329931D1 (de) 2009-12-17
US20070065819A1 (en) 2007-03-22
AU2003277575A1 (en) 2004-06-07
US7943137B2 (en) 2011-05-17
WO2004041850A1 (ja) 2004-05-21
EP1559721A1 (de) 2005-08-03
EP1559721B1 (de) 2009-11-04
EP1559721A4 (de) 2006-03-29

Similar Documents

Publication Publication Date Title
DK2308855T3 (da) 2,4-Diaminopyrimidinderivater
DE60332320D1 (de) Neues screening-verfahren
IL176674A0 (en) Fc region variants
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
DE69932738D1 (de) 3-azabicyclo(3.1.0)hexanderivate als opiat rezeptoren liganden
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60325493D1 (de) Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
EP1700120A4 (de) Marker für neuromyelitis optica
DE60335216D1 (de) Adiponektin-rezeptor und dafür kodierendes gen
PT1454992E (pt) Ensaio de quinase do linfoma anaplastico, reagentes e composicoes
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
DK1645626T3 (da) Cellelinie
PL373119A1 (en) Quality assays for antigen presenting cells
ITTO20020117A0 (it) Apparecchiatura per prove tribologiche.
ATE447586T1 (de) Fprl1-liganden und deren verwendung
EA200500878A1 (ru) Кальцилитические соединения
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
DE602004030899D1 (de) Neues screening-verfahren
ATE511644T1 (de) Neues screening-verfahren
WO2003082320A1 (fr) Nouveau procede de criblage
WO2005100386A3 (en) Canine cold-and menthol-sensitive receptor 1
DE602004023493D1 (de) Neues screening-verfahren
AU2003296620A8 (en) Screening method for identifying substances active against halitosis, gingivitis or parodontitis
ATE497946T1 (de) Substituierte benzoylureido-o-benzoylamide, verfahren zu deren herstellung und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties